Estée Lauder Shares Rise 5.2% as Q1 Earnings Beat Forecasts and FY2027 Outlook Improves
Estée Lauder (EL) shares rose 5.2% premarket after Q1 FY2027 earnings beat estimates, with adjusted EPS of $0.72 vs. $0.51 expected. Revenue grew 7% YoY to $3.72B, exceeding forecasts. Fragrance sales surged 20%, and skincare grew 4%. The company raised FY2027 guidance for organic sales, EPS, and margins, citing progress under its Beauty Reimagined strategy.
How this was made

The 30-second read
Why it matters
The earnings beat and guidance lift are likely to drive continued buying interest, especially from investors focused on premium beauty brands.
Market read
The report provides fresh, material data that can affect EL's price and the broader consumer discretionary sector.
What to watch
Potential headwinds from currency weakness and slower recovery in emerging markets could temper long‑term growth.
Background
Estée Lauder reported stronger‑than‑expected Q1 results, raising FY2027 outlook amid its Beauty Reimagined strategy.
Ticker impact
Q1 fiscal 2027 earnings beat expectations and raised full-year sales, EPS and margin guidance, driving a 5.2% pre‑market price rise.
upward pressure as investors price in higher sales growth and margins
The beat was 41% above consensus and guidance was lifted, a material catalyst for a large‑cap consumer stock.
Market effects
Boosts sentiment for the beauty and consumer discretionary sector as the earnings beat suggests resilient demand.
Supports US equity markets, especially consumer stocks, in early trading.
Limited to US and global luxury beauty markets, but may influence peers worldwide.
Counterpoint
If the guidance raise is already priced in, the stock could face a short‑term pull‑back after the initial rally.
Key entities
- companyThe Estée Lauder Companies Inc.
US‑listed beauty products group (ticker EL) reporting Q1 FY2027 results.
- executiveStéphane de La Faverie
CEO who highlighted progress under the Beauty Reimagined strategy.



